Related Experiment Video
Updated: Jul 13, 2026
08:39
Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
7.8K
Minimizing Metabolic and Cardiac Risk Factors to Maximize Outcomes After Liver Transplantation
Kathryn Schmidt1, Ashley Spann2, Mohammad Qasim Khan3
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Transplantation
|December 7, 2023
Summary
Cardiovascular disease (CVD) is a major post-liver transplant complication. This review focuses on strategies to minimize cardiometabolic disease risk and reduce mortality in liver transplant recipients with metabolic syndrome and CVD.
Area of Science:
- Cardiology
- Hepatology
- Transplantation Medicine
Background:
- Cardiovascular disease (CVD) is a significant complication following liver transplantation.
- Key risk factors include advanced age, pre-existing CVD, nonalcoholic fatty liver disease, chronic kidney disease, and metabolic syndrome.
Purpose of the Study:
- To review current strategies for minimizing cardiometabolic disease burden in liver transplant recipients.
- To identify potential interventions for reducing mortality associated with metabolic syndrome and CVD post-transplant.
Main Methods:
- Literature review of contemporary strategies.
- Analysis of risk factors for post-liver transplant CVD.
- Exploration of intervention areas for metabolic syndrome and CVD.
Main Results:
- Identification of major risk factors contributing to CVD post-liver transplantation.
- Overview of current approaches to manage cardiometabolic risk.
- Highlighting areas for future research and clinical intervention.
Conclusions:
- Minimizing cardiometabolic disease burden is crucial for improving outcomes in liver transplant recipients.
- Targeted interventions are needed to reduce mortality in patients with metabolic syndrome and CVD after liver transplantation.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...